Sorry for the very late response. I was blocked at first and then things got crazy for a while. I have been following RDGL for almost 2 years now and have been accumulating little by little.
Things are going in the right direction for Vivos now. I have been working on several oncology programs. Most are tumoristatic and none achieve the level of efficacy observed with IsoPet. Once RadioGel is in humans and clinicians learn how to use it I would not be surprised if the demand will grow quickly since it can kill any solid tumor. I hope the share price will move accordingly and then we can all retire...
Market Data 
Markets 
AI
